Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders
Hiroe Hu, Mihriye Mete, Neil K Rustgi, Charisma I. Washington, Kavya Sanghavi, M. Dutton, Naomi M Simon, Amanda W Baker, Eric Bui, Elizabeth A Hoge
JAMA Network Open October 1, 2024 DOI: 10.1001/jamanetworkopen.2024.38453 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized Peer reviewed |
|---|---|
| Topics | Anxiety Meditation |
Abstract
This secondary analysis of a randomized clinical trial assesses patient-reported anxiety, depression, and quality of life among patients receiving mindfulness-based stress reduction vs escitalopram for the treatment of anxiety disorders.
Citations in the library
Cited by 2
- Psychological trajectories following brief mindfulness training: a longitudinal comparison of active and passive controls Frontiers in Psychology August 26, 2026
- Mindfulness-based intervention for patients with generalized anxiety disorder: a randomized controlled trial. Frontiers in Psychiatry 2026
Cites 4
- Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. JAMA Psychiatry January 1, 2023
- Treatment for anxiety: Mindfulness meditation versus escitalopram (TAME): Design of a randomized, controlled non-inferiority trial. Contemporary Clinical Trials February 19, 2020
- The Effectiveness of Mindfulness-Based Cognitive Therapy on Iranian Female Adolescents Suffering From Social Anxiety. Iranian Red Crescent medical journal November 2016
- The Effect of Mindfulness-Based Therapy on Anxiety and Depression: A Meta-Analytic Review Journal of Consulting and Clinical Psychology April 1, 2010